OPTIMIZING LENTIVIRAL VECTOR PRODUCTION FOR CELL THERAPIES: ADVANCING MANUFACTURING STRATEGIES AT OMNIABIO

被引：0

作者：

Al Asafen, H. ^{[2
]}

Sudarsan, A. K. ^{[1
]}

Mcleod, A. ^{[2
]}

Kawka, K. ^{[2
]}

Maystrenko, A. ^{[2
]}

Sirskyj, D. ^{[2
]}

Bagheri, M. ^{[3
]}

Attignon, E. ^{[3
]}

Chettiar, D. ^{[1
]}

Beaudette, P. ^{[1
]}

Razvi, A. ^{[2
]}

Patel, N. ^{[1
]}

McNally, K. ^{[4
]}

Gacerez, A. ^{[4
]}

Fardy, M. ^{[4
]}

机构：

[1] Ctr Commercializat Regenerat Med, Toronto, ON, Canada

[2] Cytiva US, Marlborough, MA USA

[3] OmniaBio, Toronto, ON, Canada

[4] Chimera Bioengn, San Francisco, CA USA

来源：

CYTOTHERAPY | 2024年 / 26卷 / 06期

关键词：

lentivirus; bioreactor; process development;

D O I：

暂无

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

1143

引用

页码：E29 / E30

页数：2

共 50 条

[31] Suspension-Based Process for Lentiviral Vector Production Using a Stable Inducible Cell Line
Andreev, Nadejda
Misic, Vanja
Kim, Howard
Dulgar-Tulloch, Aaron
Timmins, Nick
MOLECULAR THERAPY, 2017, 25 (05) : 224 - 224
[32] Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor
Powers, Alicia D.
Drury, Jason E.
Hoehamer, Christopher F.
Lockey, Timothy D.
Meagher, Michael M.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 1 - 13
[33] Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy
Tang, Qu-Lai
Gu, Li-Xing
Xu, Yao
Liao, Xing-Hua
Zhou, Yong
Zhang, Tong-Cun
BIOENGINEERED, 2021, 12 (01) : 2095 - 2105
[34] Characterization of Lentiviral Vector Derived Anti-Bcma CAR T Cells Reveals Key Parameters for Robust Manufacturing of Cell-Based Gene Therapies for Multiple Myeloma
Lilley, Graham
Ladd, Alden
Cossette, Daniel
Viggiano, Laura
Hopkins, Gregory
Evans, John W.
Li, Mingli
Latimer, Howard J.
Miller, Sara M.
Kuczewski, Michael
Bakeman, Wendy
MacLeod, Kayla
Friedman, Kevin M.
Maier, Dawn A.
Peglia, Michael
Morgan, Richard A.
Angelino, Mark D.
BLOOD, 2015, 126 (23)
[35] Development of a Stable Producer Cell Line for Scalable Lentiviral Vector Production for Gene Therapy of Hemoglobinopathie
Slauson, Sarah
Thomas, Amelia
Ryu, Byoung
Bonner, Melissa
Lewis, Gretchen
Veres, Gabor
Chung, Janet
Parsons, Geoffrey B.
MOLECULAR THERAPY, 2016, 24 : S182 - S182
[36] Development of an In-House Suspension Lentiviral Vector Production Cell Line to Accelerate Manufacture of Cell Therapy Products
Gutierrez, Joshua
MOLECULAR THERAPY, 2023, 31 (04) : 381 - 381
[37] Exploring Innovative Methods for Enhancing Lentiviral Vector Yield and Target Cell Infectivity in CAR-T Cell Therapy Manufacturing
Munkacsi, Hannah
Lou, Chih Hong
MOLECULAR THERAPY, 2023, 31 (04) : 513 - 513
[38] Generation of cGMP-compliant stable packaging and producer cell lines for inducible lentiviral vector production
Dunajova, L.
Krakowiak, J.
Zgrundo, Z.
Parker-Manuel, R.
Su, W.
Seymour, L.
Cawood, R.
Liu, Q.
Payne, T.
HUMAN GENE THERAPY, 2018, 29 (12) : A161 - A161
[39] Generation of cGMP-Compliant Stable Packaging and Producer Cell Lines for Inducible Lentiviral Vector Production
Liu, Qian
MOLECULAR THERAPY, 2019, 27 (04) : 161 - 161
[40] Development and characterisation of cGMP-compliant stable packaging cell line for inducible lentiviral vector production
Tomas, H.
Krakowiak, J.
Efstathiou, A.
Page, E.
Parker-Manuel, R.
Dunajova, L.
Zhang, L.
Liu, Q.
Cawood, R.
Payne, T.
HUMAN GENE THERAPY, 2019, 30 (08) : A26 - A26

← 1 2 3 4 5 →